The role of SMAD4 in early-onset colorectal cancer

Colorectal Disease

Volumn 12, Issue 3, 2010, Pages 213-219

  Royce, S G ^a   Alsop, K ^a   Haydon, A ^c   Mead, L ^a   Smith, L D ^a   Tesoriero, A A ^a   Giles, G G ^d   Jenkins, M A ^b   Hopper, J L ^b   Southey, M C ^e  

^a Genetic Epidemiology Laboratory   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c MONASH UNIVERSITY   (Australia)

^d CANCER EPIDEMIOLOGY CENTRE   (Australia)

^e INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

Author keywords

18q; Copy number; Early onset colorectal cancer; SMAD4

Indexed keywords

K RAS PROTEIN; SMAD4 PROTEIN; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 2;

ADULT; ARTICLE; CANCER PATIENT; CASE STUDY; COLORECTAL CANCER; EARLY CANCER; FAMILY HISTORY; FAMILY STUDY; FEMALE; GENE DOSAGE; GENE MUTATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MICROSATELLITE INSTABILITY; MISMATCH REPAIR; NUCLEOTIDE REPEAT; ONSET AGE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION;

ADENOCARCINOMA; ADOLESCENT; ADULT; COLORECTAL NEOPLASMS; DNA COPY NUMBER VARIATIONS; FEMALE; HUMANS; MALE; SMAD4 PROTEIN; YOUNG ADULT;

EID: 77954351635     PISSN: 14628910     EISSN: 14631318     Source Type: Journal    
DOI: 10.1111/j.1463-1318.2009.01779.x     Document Type: Article

References (18)

1. Seshimo I, Yamamoto H, Mishima H. Expression and mutation of SMAD4 in poorly differentiated carcinoma and signet-ring cell carcinoma of the colorectum. J Exp Clin Cancer Res 2006, 25:433-42.
2. Alazzouzi H, Alhopuro P, Salovaara R. SMAD4 as a prognostic marker in colorectal cancer. Clin Cancer Res 2005, 11:2606-11.
3. Alhopuro P, Alazzouzi H, Sammalkorpi H. SMAD4 levels and response to 5-fluorouracil in colorectal cancer. Clin Cancer Res 2005, 11:6311-6.
4. Zhou S, Kinzler KW, Vogelstein B. Going mad with Smads. N Engl J Med 1999, 341:1144-6.
5. Isaksson-Mettävainio M, Palmqvist R, Forssell J, Stenling R, Oberg A. SMAD4/DPC4 expression and prognosis in human colorectal cancer. Anticancer Res 2006, 26:507-10.
6. Korchynskyi O, Landstrom M, Stoika R, Funa K, Heldin CH, ten Dijke P, Souchelnytskyi S. Expression of Smad proteins in human colorectal cancer. Int J Cancer 1999, 82:197.
7. Salovaara R, Roth S, Loukola A. Frequent loss of SMAD4/DPC4 protein in colorectal cancers. Gut 2002, 51:56-9.
8. Tanaka T, Watanabe T, Kazama Y. Chromosome 18q deletion and Smad4 protein inactivation correlate with liver metastasis: a study matched for T- and N- classification. Br J Cancer 2006, 95:1562-7. Epub 2006 Nov 7
9. Southey MC, Jenkins MA, Mead L. Mismatch repair gene mutation testing, immunohistochemistry and microsatellite instability testing in a population-based series of unselected early-onset colorectal cancers. J Clin Oncol 2005, 23:6524-32.
10. Mead LJ, Jenkins MA, Young J. Microsatellite instability markers for identifying early-onset colorectal cancers caused by germ-line mutations in DNA mismatch repair genes. Clin Cancer Res 2007, 13:2865-9.
11. Alsop K, Mead L, Smith LD. Low somatic K-ras mutation frequency in colorectal cancer diagnosed under the age of 45 years. Eur J Cancer 2006, 42:1357-61.
12. Jenkins MA, Baglietto L, Dite GS. After hMSH2 and hMLH1--what next? Analysis of three-generational, population-based, early-onset colorectal cancer families. Int J Cancer 2002, 102:166-71.
13. Armes JE, Trute L, White D. Distinct molecular pathogeneses of early-onset breast cancers in BRCA1 and BRCA2 mutation carriers: a population-based study. Cancer Res 1999, 59:2011-7.
14. Boulay JL, Reuter J, Ritschard R, Terracciano L, Herrmann R, Rochlitz C. Gene dosage by quantitative real-time PCR. BioTechniques 1999, 27:228-30.
15. Boulay JL, Mild G, Lowy A. SMAD4 is a predictive marker for 5-fluorouracil-based chemotherapy in patients with colorectal cancer. Br J Cancer 2002, 87:630-4. Erratum in: Br J Cancer. 2003 Jul 21;89(2):422
16. Vasen HF, Watson P, Mecklin JP, Lynch HT. New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative group on HNPCC. Gastroenterology 1999, 116:1453-6.
17. Montgomery E, Goggins M, Zhou S. Nuclear localization of Dpc4 (Madh4, Smad4) in colorectal carcinomas and relation to mismatch repair/transforming growth factor-beta receptor defects. Am J Pathol 2001, 158:537-42.
18. Wilentz RE, Iacobuzio-Donahue CA, Argani P. Loss of expression of Dpc4 in pancreatic intraepithelial neoplasia: evidence that DPC4 inactivation occurs late in neoplastic progression. Cancer Res 2000, 60:2002-6.